Search Menu


The valuable task of developing the next generation drug candidates is heavily dependent on the next round of funding, whereas convincing investors to financially support a drug R&D program depends on the quality of the underlying research data.

The experts at PAASP worked for several years in academic and industrial research organizations and have developed a fast and cost-effective approach (PAASPort®) how to ensure and monitor research quality, right from the start of your project. Being able to present data sets of highest quality will accelerate the funding process and increase the chances to obtain the next crucial round of financing.

Please contact us for more information.

Scroll Up